awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37022524-4C5047D2-6F50-4FC8-BE40-1B970DAA1E02
Q37022524-4C5047D2-6F50-4FC8-BE40-1B970DAA1E02
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37022524-4C5047D2-6F50-4FC8-BE40-1B970DAA1E02
The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer
P2860
Q37022524-4C5047D2-6F50-4FC8-BE40-1B970DAA1E02
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37022524-4C5047D2-6F50-4FC8-BE40-1B970DAA1E02
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fbf5441ca4ea741c442b13aa22bc4b21fcfa3201
P2860
CA-125 can be part of the tumour evaluation criteria in ovarian cancer trials: experience of the GCIG CALYPSO trial